See also this year's filing and all EDGAR filings for this company.
PDF Report 0001815974_2024_Anebulo_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001815974, Anebulo Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,670,151 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 534,545 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 534,256 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,183,402 |
| 9 | ResearchAndDevelopmentExpense | 5,600,197 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 51,261 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,670,151 |
| 1 | Liabilities | 1,068,801 |
| 2 | Expenses | 11,783,599 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 10,601,350 |
| 5 | NetIncome | -11,732,338 |
| 6 | ComprehensiveNetIncome | -11,732,338 |
| 7 | BaseVar | 12,286,906 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.79 |
| 9 | EconomicCapitalRatio | 2.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
